The axolotl, a type of salamander that stays in the tadpole form throughout its life, is a master of regeneration. Axolotls ...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...

On December 8, 2025, Wave Life Sciences will unveil interim data from its Phase 1 INLIGHT trial, focusing on WVE-007, a promising treatment for obesity. This article explores the trial's significance, ...

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

Drug–induced liver injury appears more common in patients on tuberculosis therapy with chronic hepatitis C virus infection.

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

A study funded in part by the National Institutes of Health (NIH) has revealed important insights into the genetics of ...

Spinal Cord Injury (SCI) is a devastating neurological disorder that often leads to permanent neural dysfunction. Current treatments fail to address ...

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one ...

Cottonseeds could help reduce hunger and add new revenue for farmers. One researcher has been working for decades to make ...